Risankizumab

CAT: 0804-HY-P99248-01Size: 1 mgDry Ice: YesHazardous: No
CAT#:0804-HY-P99248-01Size:1 mg
Selected
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Risankizumab (BI 655066) is a humanised IgG monoclonal antibody, targeting IL-23 p19 subunit (Kd 50 = 2 pM) . Risankizumab can be used to research immunological and inflammatory disorders such as psoriasis vulgaris, psoriatic arthritis, generalized pustular psoriasis and erythrodermic psoriasis[1][2][3].
CAS Number
[1612838-76-2]
Product Name Alternative
Risankizumab rzaa; BI 655066; ABBV-066
UNSPSC
12352203
Target
Interleukin Related
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/risankizumab.html
Purity
99.37
Solubility
10 mM in DMSO
Smiles
[Risankizumab]
Molecular Weight
(145.92 kDa)
References & Citations
[1]McKeage K, Duggan S. Risankizumab: First Global Approval. Drugs. 2019 Jun;79 (8) :893-900.|[2]Andrea Chiricozzi, et al. Risankizumab for the treatment of moderate to severe psoriasis. Expert Opinion on Biological Therapy. Volume 19, 2019 - Issue 1|[3]Singh S, et al. Selective targeting of the IL23 pathway: Generation and characterization of a novel high-affinity humanized anti-IL23A antibody. MAbs. 2015;7 (4) :778-91.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Launched
Isoform
IL-23

Related Products

CatalogName

Popular Products